Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study
Authors
Ricardo M. La Hoz (ORCID: https://orcid.org/0000-0002-1560-3192)
Aimee K. Sundberg (ORCID: https://orcid.org/0000-0002-7739-3135)
Emily A. Blumberg (ORCID: https://orcid.org/0000-0002-5193-6170)
Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study
Ricardo M. La Hoz, Aimee K. Sundberg, Emily A. Blumberg, Nassim Kamar et al.
Citations
13 citations
Journal
The Journal of Heart and Lung Transplantation
Topics
Cytomegalovirus and herpesvirus research
Field-Weighted Citation Impact (FWCI)
5.03
article
Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study
Ricardo M. La Hoz, Aimee K. Sundberg, Emily A. Blumberg, Nassim Kamar, Deepali Kumar, Michael G. Ison, Oliver Witzke, Faouzi Saliba, Joan Gu
article en
13 citations
Abstract
No abstract available for this paper.
Publication Tag
The Journal of Heart and Lung TransplantationVol. 44(6)
Institutions
Centre National de la Recherche Scientifique (FR), University Health Network (CA), Université Toulouse III - Paul Sabatier (FR), Inserm (FR), Royal Free London NHS Foundation Trust (GB), Université Fédérale de Toulouse Midi-Pyrénées (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Rangueil (FR), Development Services Group (United States) (US), Takeda (United States) (US), West German Heart and Vascular Center Essen (DE), Hôpital Paul-Brousse (FR), University College London (GB), University of Duisburg-Essen (DE), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US)